Top

Published in:

01-01-2016

Venous Thromboembolism Prophylaxis in Liver Surgery

Authors: Thomas A. Aloia, William H. Geerts, Bryan M. Clary, Ryan W. Day, Alan W. Hemming, Luiz Carneiro D’Albuquerque, Charles M. Vollmer Jr., Jean-Nicolas Vauthey, Giles J. Toogood

Published in: Journal of Gastrointestinal Surgery | Issue 1/2016

Abstract

Background

At a recently concluded Americas Hepato-Pancreato-Biliary Association Annual Meeting, a Clinical Practice Guidelines Conference Series was convened with the topic focusing on Venous Thromboembolism (VTE) Prophylaxis in Liver Surgery. The symposium brought together hepatobiliary surgeons from three continents as well as medical experts in hematology and coagulation.

Methods

The content of the discussion included literature reviews, evaluation of multi-institutional VTE outcome data, and examination of practice patterns at multiple high-volume centers.

Results

Literature review demonstrated that, within gastrointestinal surgery, liver resection patients are at particularly high-risk for VTE. Recent evidence clearly indicates a direct relationship between the magnitude of hepatectomy and postoperative VTE rates, however, the PT/INR does not accurately reflect the coagulation status of the post-hepatectomy patient. Evaluation of available data and practice patterns regarding the utilization and timing of anticoagulant VTE prophylaxis led to recommendations regarding preoperative and postoperative thromboprophylaxis for liver surgery patients.

Conclusions

This conference was effective in consolidating our knowledge of coagulation abnormalities after liver resection. Based on the expert review of the available data and practice patterns, a number of recommendations were developed.

Reddy SK, Turley RS, Barbas AS, Steel JL, Tsung A, Marsh JW, Clary BM and Geller DA. Post-operative pharmacologic thromboprophylaxis after major hepatectomy: does peripheral venous thromboembolism prevention outweigh bleeding risks? J Gastrointest Surg. 2011;15(9):1602-1610.PubMedCrossRef

Turley RS, Reddy SK, Shortell CK, Clary BM and Scarborough JE. Venous thromboembolism after hepatic resection: analysis of 5,706 patients. J Gastrointest Surg. 2012;16(9):1705-1714.PubMedCrossRef

Potze W, Alkozai EM, Adelmeijer J, Porte RJ and Lisman T. Hypercoagulability following major partial liver resection - detected by thrombomodulin-modified thrombin generation testing. Aliment Pharmacol Ther. 2015;41(2):189-198.

Nathan H, Weiss MJ, Soff GA, Stempel M, Dematteo RP, Allen PJ, Kingham TP, Fong Y, Jarnagin WR and D'angelica MI. Pharmacologic prophylaxis, postoperative INR, and risk of venous thromboembolism after hepatectomy. J Gastrointest Surg. 2014;18(2):295-302; discussion 302-293.PubMedCrossRef

Ejaz A, Spolverato G, Kim Y, Lucas DL, Lau B, Weiss M, Johnston FM, Kheng M, Hirose K, Wolfgang CL, Haut E and Pawlik TM. Defining incidence and risk factors of venous thromboemolism after hepatectomy. J Gastrointest Surg. 2014;18(6):1116-1124.PubMedPubMedCentralCrossRef

Aloia TA, Fahy BN, Fischer CP, Jones SL, Duchini A, Galati J, Gaber AO, Ghobrial RM and Bass BL. Predicting poor outcome following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database. HPB (Oxford). 2009;11(6):510-515.PubMedCentralCrossRef

Tzeng CW, Katz MH, Fleming JB, Pisters PW, Lee JE, Abdalla EK, Curley SA, Vauthey JN and Aloia TA. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford). 2012;14(8):506-513.PubMedCentralCrossRef

Dabbagh O, Oza A, Prakash S, Sunna R and Saettele TM. Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease. Chest. 2010;137(5):1145-1149.PubMedCrossRef

Schwartz J, Vargas G, Thiesset H, Stoddard G, Kim R, Sorensen J and Kraiss L. Revisiting the issue of VTE in the setting of chronic liver disease: an examination of National Surgical Quality Improvement Program data. Chest. 2011;139(6):1544-1545.PubMedCrossRef

10.

Mukherjee D, Lidor AO, Chu KM, Gearhart SL, Haut ER and Chang DC. Postoperative venous thromboembolism rates vary significantly after different types of major abdominal operations. J Gastrointest Surg. 2008;12(11):2015-2022.PubMedCrossRef

11.

White RH, Zhou H and Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost. 2003;90(3):446-455.PubMed

12.

Lisman T and Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood. 2010;116(6):878-885.PubMedCrossRef

13.

Bezeaud A, Denninger MH, Dondero F, Saada V, Venisse L, Huisse MG, Belghiti J and Guillin MC. Hypercoagulability after partial liver resection. Thromb Haemost. 2007;98(6):1252-1256.PubMed

14.

Roberts LN, Patel RK and Arya R. Haemostasis and thrombosis in liver disease. Br J Haematol. 2010;148(4):507-521.PubMedCrossRef

15.

Tripodi A, Primignani M, Chantarangkul V, Dell'era A, Clerici M, De Franchis R, Colombo M and Mannucci PM. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology. 2009;137(6):2105-2111.PubMedCrossRef

16.

Barton JS, Riha GM, Differding JA, Underwood SJ, Curren JL, Sheppard BC, Pommier RF, Orloff SL, Schreiber MA and Billingsley KG. Coagulopathy after a liver resection: is it over diagnosed and over treated? HPB (Oxford). 2013.

17.

Louis SG, Barton JS, Riha GM, Orloff SL, Sheppard BC, Pommier RF, Underwood SJ, Differding JA, Schreiber MA and Billingsley KG. The international normalized ratio overestimates coagulopathy in patients after major hepatectomy. Am J Surg. 2014;207(5):723-727; discussion 727.PubMedCrossRef

18.

Martin RC, 2nd, Jarnagin WR, Fong Y, Biernacki P, Blumgart LH and Dematteo RP. The use of fresh frozen plasma after major hepatic resection for colorectal metastasis: is there a standard for transfusion? J Am Coll Surg. 2003;196(3):402-409.PubMedCrossRef

19.

Gagandeep S, Jabbour N, Genyk Y and Selby R. Restricting fresh frozen plasma in hepatic resections. J Am Coll Surg. 2003;197(2):339-340.PubMedCrossRef

20.

Tripodi A, Caldwell SH, Hoffman M, Trotter JF and Sanyal AJ. Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease. Aliment Pharmacol Ther. 2007;26(2):141-148.PubMedCrossRef

21.

Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M and Mannuccio Mannucci P. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005;41(3):553-558.PubMedCrossRef

22.

Lisman T, Caldwell SH, Burroughs AK, Northup PG, Senzolo M, Stravitz RT, Tripodi A, Trotter JF, Valla DC and Porte RJ. Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol. 2010;53(2):362-371.PubMedCrossRef

23.

Lisman T, Bakhtiari K, Pereboom IT, Hendriks HG, Meijers JC and Porte RJ. Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. J Hepatol. 2010;52(3):355-361.PubMedCrossRef

24.

Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D and Durand F. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242(6):824-828, discussion 828-829.PubMedPubMedCentralCrossRef

25.

Cerutti E, Stratta C, Romagnoli R, Schellino MM, Skurzak S, Rizzetto M, Tamponi G and Salizzoni M. Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation. Liver Transpl. 2004;10(2):289-294.PubMedCrossRef

26.

Vieira Da Rocha EC, D'amico EA, Caldwell SH, Flores Da Rocha TR, Soares ESCS, Dos Santos Bomfim V, Felga G, Barbosa WF, Kassab F, Polli DA, Carrilho FJ and Farias AQ. A prospective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation. Clin Gastroenterol Hepatol. 2009;7(9):988-993.PubMedCrossRef

27.

Schofield N, Sugavanam A, Henley M, Thompson K, Riddell A and Mallett SV. An in vitro study comparing two dose regimes of fresh frozen plasma on conventional and thromboelastographic tests of coagulation after major hepatic resection. Transfus Med. 2015.

28.

Hull RD, Pineo GF, Francis C, Bergqvist D, Fellenius C, Soderberg K, Holmqvist A, Mant M, Dear R, Baylis B, Mah A and Brant R. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators. Arch Intern Med. 2000;160(14):2199-2207.PubMedCrossRef

29.

Sachdeva A, Dalton M, Amaragiri SV and Lees T. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev. 2010(7):CD001484.PubMed

30.

Ho KM and Tan JA. Stratified meta-analysis of intermittent pneumatic compression of the lower limbs to prevent venous thromboembolism in hospitalized patients. Circulation. 2013;128(9):1003-1020.PubMedCrossRef

31.

Morris RJ and Woodcock JP. Intermittent pneumatic compression or graduated compression stockings for deep vein thrombosis prophylaxis? A systematic review of direct clinical comparisons. Ann Surg. 2010;251(3):393-396.PubMedCrossRef

32.

Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM and American College of Chest P. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e227S-277S.PubMedPubMedCentral

33.

Bergqvist D, Burmark US, Flordal PA, Frisell J, Hallbook T, Hedberg M, Horn A, Kelty E, Kvitting P, Lindhagen A, Et Al. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients. Br J Surg. 1995;82(4):496-501.PubMedCrossRef

34.

Collins R, Scrimgeour A, Yusuf S and Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med. 1988;318(18):1162-1173.PubMedCrossRef

35.

Leonardi MJ, Mcgory ML and Ko CY. A systematic review of deep venous thrombosis prophylaxis in cancer patients: implications for improving quality. Ann Surg Oncol. 2007;14(2):929-936.PubMedCrossRef

36.

Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A and Dietrich-Neto F. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346(13):975-980.PubMedCrossRef

37.

Rasmussen MS, Jorgensen LN, Wille-Jorgensen P, Nielsen JD, Horn A, Mohn AC, Somod L and Olsen B. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study. J Thromb Haemost. 2006;4(11):2384-2390.PubMedCrossRef

38.

Kakkar VV, Balibrea JL, Martinez-Gonzalez J and Prandoni P. Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study. J Thromb Haemost. 2010;8(6):1223-1229.PubMedCrossRef

39.

Akl EA, Terrenato I, Barba M, Sperati F, Muti P and Schunemann HJ. Extended perioperative thromboprophylaxis in patients with cancer. A systematic review. Thromb Haemost. 2008;100(6):1176-1180.PubMed

40.

Tzeng CD, Curley SA, Vauthey JN and Aloia TA. Distinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: Analysis of 7,621 NSQIP patients. HPB. 2013;15(S1):79.

41.

Morris-Stiff G, White A, Gomez D, Toogood G, Lodge JP and Prasad KR. Thrombotic complications following liver resection for colorectal metastases are preventable. HPB (Oxford). 2008;10(5):311-314.CrossRef

42.

Raoof M, Aloia TA, Vauthey JN and Curley SA. Morbidity and mortality in 1,174 patients undergoing hepatic parenchymal transection using a stapler device. Ann Surg Oncol. 2014;21(3):995-1001.PubMedCrossRef

43.

Excellence. NIFHaC. Venous thromboembolism: reducing the risk. 2010.

44.

Weiss MJ, Kim Y, Ejaz A, Spolverato G, Haut ER, Hirose K, Wolfgang CL, Choti MA and Pawlik TM. Venous thromboembolic prophylaxis after a hepatic resection: patterns of care among liver surgeons. HPB (Oxford). 2014;16(10):892-898.CrossRef

45.

Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA, Jr. and Caprini JA. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2010;251(2):344-350.PubMedCrossRef

46.

Huo MH and Muntz J. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: A review. Clin Ther. 2009;31(6):1129-1141.

Title: Venous Thromboembolism Prophylaxis in Liver Surgery
Authors: Thomas A. Aloia
William H. Geerts
Bryan M. Clary
Ryan W. Day
Alan W. Hemming
Luiz Carneiro D’Albuquerque
Charles M. Vollmer Jr.
Jean-Nicolas Vauthey
Giles J. Toogood
Publication date: 01-01-2016
Publisher: Springer US
Published in: Journal of Gastrointestinal Surgery / Issue 1/2016
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-015-2902-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Venous Thromboembolism Prophylaxis in Liver Surgery

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2016

Use of Preoperative Magnetic Resonance Imaging to Select Patients with Rectal Cancer for Neoadjuvant Chemoradiation—Interim Analysis of the German OCUM Trial (NCT01325649)

Retraction Note: Does the hepatic branch of vagus mediate the secretion of glucagon-like peptide-1 during the Roux-en-Y gastric bypass surgery

Minnelide Overcomes Oxaliplatin Resistance by Downregulating the DNA Repair Pathway in Pancreatic Cancer

Watch and Wait?—Elevated Pretreatment CEA Is Associated with Decreased Pathological Complete Response in Rectal Cancer

Intra-gastric Ectopic Splenic Tissue

Metabolic Syndrome is Associated with Increased Postoperative Morbidity and Hospital Resource Utilization in Patients Undergoing Elective Pancreatectomy